[Federal Register Volume 69, Number 153 (Tuesday, August 10, 2004)]
[Notices]
[Page 48525]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-18181]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to 21 CFR 1301.33(a), this is notice that on April 29, 
2004, Syva Company, Dade Behring Inc., Regulatory Affairs Dept 
1-310, 20400 Mariani Avenue, Cupertino, California 95014, made 
application by renewal to the Drug Enforcement Administration (DEA) for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed below, and by letter dated July 6, 2004, to modify 
its name to Dade Behring, Inc.

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Tetrahydrocannabionols (7370)..............  I
Ecgonine (9180)............................  II
Morphine (9300)............................  II
------------------------------------------------------------------------

    The company plans to produce bulk products used for the manufacture 
of reagents and drug calibrator/controls, DEA exempt products.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such a substance may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCD) and must be filed no later than October 12, 2004.

    Dated: July 21, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 04-18181 Filed 8-9-04; 8:45 am]
BILLING CODE 4410-01-M